A Study of BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia
Clinical trial NCT07255872 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07255872
- Sponsor
- Sichuan Baili Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-01
- Primary completion
- 2027-12-01
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.